Search research articles
Contact Us
Filters
Showing results (351-360 of 386) with videos related to
Page
of 39
Sort By:
Blood
|
May 16, 2024
Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib
Jennifer A Woyach, Daniel Jones, Wojciech Jurczak, et al.
Cell Reports
|
April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N Faraone, John P Evans, et al.
Cell Reports
|
July 18, 2024
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Pei Li, Julia N Faraone, Cheng Chih Hsu, et al.
Mbio
|
April 9, 2024
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
Pei Li, Yajie Liu, Julia N Faraone, et al.
JAMA Oncology
|
March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
Heather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 28, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Marwah Abdalla, Natalie A Bello, et al.
Journal of the American College of Cardiology
|
August 29, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Donald M Lloyd-Jones, Marwah Abdalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
Farhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Biotechnology for Biofuels
|
November 10, 2016
Inhibition of microbial biofuel production in drought-stressed switchgrass hydrolysate
Rebecca Garlock Ong, Alan Higbee, Scott Bottoms, et al.
Circulation
|
August 28, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Marwah Abdalla, Natalie A Bello, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 386) with videos related to
Sort By:
Page
of 39
Blood
|
May 16, 2024
Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib
Jennifer A Woyach, Daniel Jones, Wojciech Jurczak, et al.
Cell Reports
|
April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N Faraone, John P Evans, et al.
Cell Reports
|
July 18, 2024
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Pei Li, Julia N Faraone, Cheng Chih Hsu, et al.
Mbio
|
April 9, 2024
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
Pei Li, Yajie Liu, Julia N Faraone, et al.
JAMA Oncology
|
March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
Heather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 28, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Marwah Abdalla, Natalie A Bello, et al.
Journal of the American College of Cardiology
|
August 29, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Donald M Lloyd-Jones, Marwah Abdalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
Farhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Biotechnology for Biofuels
|
November 10, 2016
Inhibition of microbial biofuel production in drought-stressed switchgrass hydrolysate
Rebecca Garlock Ong, Alan Higbee, Scott Bottoms, et al.
Circulation
|
August 28, 2025
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S Khan, Marwah Abdalla, Natalie A Bello, et al.
Page
of 39